phenytoin has been researched along with Cancer of Prostate in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 46 year old male patient with metastatic prostate cancer developed Stevens-Johnson syndrome (SJS), initially in three well-demarcated areas on his scalp, chest and back, corresponding to ports of radiation therapy while on phenytoin." | 7.76 | Multifocal Stevens-Johnson syndrome after concurrent phenytoin and cranial and thoracic radiation treatment, a case report. ( Dvorak, T; Kandil, AO; Mignano, J; Wu, JK; Zhu, JJ, 2010) |
| "A 46 year old male patient with metastatic prostate cancer developed Stevens-Johnson syndrome (SJS), initially in three well-demarcated areas on his scalp, chest and back, corresponding to ports of radiation therapy while on phenytoin." | 3.76 | Multifocal Stevens-Johnson syndrome after concurrent phenytoin and cranial and thoracic radiation treatment, a case report. ( Dvorak, T; Kandil, AO; Mignano, J; Wu, JK; Zhu, JJ, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, GC | 1 |
| Kong, Y | 1 |
| Paige, M | 1 |
| Li, Z | 1 |
| Merrick, EC | 1 |
| Hansen, T | 1 |
| Suy, S | 1 |
| Wang, K | 1 |
| Dakshanamurthy, S | 1 |
| Cordova, A | 1 |
| McManus, OB | 1 |
| Williams, BS | 1 |
| Chruszcz, M | 1 |
| Minor, W | 1 |
| Patel, MK | 2 |
| Brown, ML | 2 |
| Gartrell, BA | 1 |
| Roach, M | 1 |
| Retter, A | 1 |
| Sokol, GH | 1 |
| Del Priore, G | 1 |
| Scher, HI | 1 |
| Kandil, AO | 1 |
| Dvorak, T | 1 |
| Mignano, J | 1 |
| Wu, JK | 1 |
| Zhu, JJ | 1 |
| Yoshino, H | 1 |
| Sato, H | 1 |
| Shiraishi, T | 1 |
| Tachibana, K | 1 |
| Emura, T | 1 |
| Honma, A | 1 |
| Ishikura, N | 1 |
| Tsunenari, T | 1 |
| Watanabe, M | 1 |
| Nishimoto, A | 1 |
| Nakamura, R | 1 |
| Nakagawa, T | 1 |
| Ohta, M | 1 |
| Takata, N | 1 |
| Furumoto, K | 1 |
| Kimura, K | 1 |
| Kawata, H | 1 |
| Fraser, SP | 1 |
| Salvador, V | 1 |
| Manning, EA | 1 |
| Mizal, J | 1 |
| Altun, S | 1 |
| Raza, M | 1 |
| Berridge, RJ | 1 |
| Djamgoz, MB | 1 |
| Anderson, JD | 1 |
| Hansen, TP | 1 |
| Lenkowski, PW | 1 |
| Walls, AM | 1 |
| Choudhury, IM | 1 |
| Schenck, HA | 1 |
| Friehling, M | 1 |
| Höll, GM | 1 |
| Sikes, RA | 1 |
| Barzilay, D | 1 |
| Orion, E | 1 |
| Brenner, S | 1 |
| Zaninovich, AA | 1 |
| Farach, H | 1 |
| Ezrin, C | 1 |
| Volpé, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase 1b/2, Open-Label, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of SM88 in Patients With Prostate Cancer[NCT02796898] | Phase 1/Phase 2 | 23 participants (Actual) | Interventional | 2016-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for phenytoin and Cancer of Prostate
| Article | Year |
|---|---|
Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Humans; Kaplan-Meier Estimate; Male; Methoxsalen; Mid | 2021 |
7 other studies available for phenytoin and Cancer of Prostate
| Article | Year |
|---|---|
Asymmetric synthesis and evaluation of a hydroxyphenylamide voltage-gated sodium channel blocker in human prostate cancer xenografts.
Topics: Amides; Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Chemistry Techniques, Synthetic | 2012 |
Multifocal Stevens-Johnson syndrome after concurrent phenytoin and cranial and thoracic radiation treatment, a case report.
Topics: Anticonvulsants; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Humans; Male; Midd | 2010 |
Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer.
Topics: Androgen Antagonists; Animals; Antineoplastic Agents; Castration; Dogs; Drug Design; Ether-A-Go-Go P | 2010 |
Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility.
Topics: Aconitine; Animals; Carcinoma; Cell Division; Cell Movement; Cnidarian Venoms; Cytoskeletal Proteins | 2003 |
Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3.
Topics: Androgens; Animals; Cell Division; Cell Line, Tumor; Electrophysiology; Humans; Inhibitory Concentra | 2003 |
Porphyria cutanea tarda triggered by a combination of three predisposing factors.
Topics: Aged; Alcoholism; Gonadotropin-Releasing Hormone; Humans; Male; Phenytoin; Porphyria Cutanea Tarda; | 2001 |
Lack of significant binding of L-triiodothyronine by thyroxine-binding globulin in vivo as demonstrated by acute disappearance of 131-I-labeled triiodothyronine.
Topics: Adolescent; Adult; Aged; Epilepsy; Estrogens; Female; Hepatitis; Humans; Hyperthyroidism; Hypothyroi | 1966 |